IBX 5.88% 3.2¢ imagion biosystems limited

JOURNEY to 50c plus, page-401

  1. 411 Posts.
    lightbulb Created with Sketch. 312
    Key terms of the AgreementStatement of WorksThe Agreement is staged into phases with the first two phases being defined. Phase 1 relates to ‘Nanoscintillator Synthesis’ and is expected to have a duration of between 9-12 months with estimated costs of US$450,000-US$500,000. Phase 1 will involve Imagion developing a protocol for synthesizing the yttrium aluminum garnet nanocrystals doped with a praseodymium scintillator.Phase 2 relates to ‘Coating and Linker Chemistries’ and is expected to have a duration of between 9-12 months with estimated costs of US$450,000-US$500,000. Phase 2 will involve Imagion developing surface chemistry to enable a linker (holding a therapeutic payload) to be attached to the nanoscintillator crystals.The estimated costs above include material, labor and any third party or subcontracted costs and will be invoiced by Imagion to GCT. Neither the estimated timing or costs are binding on either party and are included within the Agreement as a guide only and are subject to change. Preliminary works have commenced in relation to Phase 1 of the Agreement.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
-0.002(5.88%)
Mkt cap ! $1.140M
Open High Low Value Volume
3.2¢ 3.2¢ 3.1¢ $1.241K 38.80K

Buyers (Bids)

No. Vol. Price($)
2 48498 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 3776 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.